Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Richard Warwick, a student at Treloar's, stated that "they were crazy about prophylactics at Treloars' and prophylaxis was used 'like every day'.

  • Read more about Richard Warwick, a student at Treloar's, stated that "they were crazy about prophylactics at Treloars' and prophylaxis was used 'like every day'.

At Treloar's NHS Concentrate was used a lot less compared to commercial concentrates.

  • Read more about At Treloar's NHS Concentrate was used a lot less compared to commercial concentrates.

Adrian Goodyear, a boy from Treloar's, stated Dr Aronstam's guilt towards the boys having contracted HIV and that the PHLS let him down by setting him up.

  • Read more about Adrian Goodyear, a boy from Treloar's, stated Dr Aronstam's guilt towards the boys having contracted HIV and that the PHLS let him down by setting him up.

Dr Aronstam told Adrian Goodyear, who attended Treloar's, that he had contracted HIV.

  • Read more about Dr Aronstam told Adrian Goodyear, who attended Treloar's, that he had contracted HIV.

Conversation between Dr Aronstam, Adrian Goodyear and some boys of Treloar's where Dr Aronstam expressed his concern and emotions regarding the boys having been infected with HIV.

  • Read more about Conversation between Dr Aronstam, Adrian Goodyear and some boys of Treloar's where Dr Aronstam expressed his concern and emotions regarding the boys having been infected with HIV.

At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1983.

  • Read more about At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1983.

At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1982.

  • Read more about At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1982.

Due to a large research grant Treloar's was able to supply students with much more blood product than their home clinicians.

  • Read more about Due to a large research grant Treloar's was able to supply students with much more blood product than their home clinicians.

The Committee on Safety of Medicines advised that the bulk cryoprecipitate was to be prepared by Alpha Therapeutic only from source plasma derived from their own licensed plasmapheresis centres. This was considered to be risky as the effects resulting from these products were uncertain.

  • Read more about The Committee on Safety of Medicines advised that the bulk cryoprecipitate was to be prepared by Alpha Therapeutic only from source plasma derived from their own licensed plasmapheresis centres. This was considered to be risky as the effects resulting from these products were uncertain.

Dr Aronstam sought a clinical trial exemption certificate to permit him to administer Mono-V3:C, a product of Speywood Laboratories, to 50 pupils over a period of 8 months.

  • Read more about Dr Aronstam sought a clinical trial exemption certificate to permit him to administer Mono-V3:C, a product of Speywood Laboratories, to 50 pupils over a period of 8 months.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 829
  • Page 830
  • Page 831
  • Page 832
  • Current page 833
  • Page 834
  • Page 835
  • Page 836
  • Page 837
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.